Oncology Market in India 2021-2025

Oncology Market in India 2021-2025

  • December 2021 •
  • 120 pages •
  • Report ID: 6191449 •
  • Format: PDF
Oncology Market in India 2021-2025
The analyst has been monitoring the oncology market in India and it is poised to grow by $ 734.18 million during 2021-2025, progressing at a CAGR of 13.02% during the forecast period. Our report on the oncology market in India provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increased prevalence of cancer and unhealthy lifestyle. In addition, increased prevalence of cancer is anticipated to boost the growth of the market as well.
The oncology market in India analysis includes the end-user and type segments.

The oncology market in India is segmented as below:
By End-User
• Hospitals
• Diagnostic Laboratories
• Diagnostic Imaging Centers
• Others

By Type
• Cancer Treatment
• Cancer Diagnostics

This study identifies the increasing geriatric populationas one of the prime reasons driving the oncology market growth in India during the next few years.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on oncology market in India covers the following areas:
• Oncology market sizing
• Oncology market forecast
• Oncology market industry analysis

This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oncology market vendors in India that include AstraZeneca Plc, Bristol-Myers Squibb Co., Cadila Healthcare Ltd., Cipla Inc., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., NATCO Pharma Ltd., Poly Medicure Ltd., Siemens Healthineers AG, and Sun Pharmaceutical Industries Ltd. Also, the oncology market in India analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.